The therapeutic potential of targeting minimal residual disease in melanoma

BACKGROUND: Cutaneous melanoma is a lethal form of skin cancer with morbidity and mortality rates highest amongst European, North American and Australasian populations. The developments of targeted therapies (TTs) directed at the oncogene BRAF and its downstream mediator MEK, and immune checkpoint i...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Riyaben P, Somasundram, Pretashini M, Smith, Lorey K., Sheppard, Karen E., McArthur, Grant A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040726/
https://www.ncbi.nlm.nih.gov/pubmed/36967556
http://dx.doi.org/10.1002/ctm2.1197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040726/
https://www.ncbi.nlm.nih.gov/pubmed/36967556
http://dx.doi.org/10.1002/ctm2.1197

Ejemplares similares